Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma

Surgery

Volumn 146, Issue 2, 2009, Pages 232-240

  Sullivan, Jennifer ^a   Blair, Laurel ^a   Alnajar, Amer ^a   Aziz, Tamer ^a   Ng, Chee Yuan ^a   Chipitsyna, Galina ^a   Gong, Qiaoke ^a   Witkiewicz, Agnes ^b   Weber, Georg F ^c   Denhardt, David T ^d   Yeo, Charles J ^a   Arafat, Hwyda A ^a,b  

^a Department of Surgery   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NICOTINE; OSTEOPONTIN; TUMOR MARKER;

ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; ULTRAVIOLET RADIATION;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; COMPUTERS, HANDHELD; HUMANS; IMMUNOHISTOCHEMISTRY; NICOTINE; OSTEOPONTIN; PANCREATIC NEOPLASMS; PROTEIN ISOFORMS; RNA, MESSENGER; SMOKING; TUMOR CELLS, CULTURED;

EID: 67650566647     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.03.036     Document Type: Article

References (25)

1. American Cancer Society. Cancer facts and figures 2007 (2007), American Cancer Society, Atlanta
2. Wang X.L., and Wang J. Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg 29 (2005) 344-353
3. Lowenfels A.B., and Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20 (2006) 197-209
4. US Department of Health and Human Services. The health consequences of using smokeless tobacco: a report of the advisory committee to the Surgeon General [NIH Publication #86-2874] (April 1986), USDHHS, Bethesda, MD
5. Farrow D.C., and Davis S. Risk of pancreatic cancer in relation to medical history and use of tobacco, alcohol and coffee. Intl J Cancer 45 (1990) 816-820
6. Silverman D.T., Dunn J.A., Hoover R.N., Schiffman M., Lillemoe K.D., Schoenberg J.B., et al. Cigarette smoking and pancreas cancer: a case control study based on direct interviews. J Natl Cancer Inst 86 (1994) 1510-1516
7. Chowdhury P., Rayford P.L., and Chang L.W. Inductions of pancreatic acinar cell pathology via inhalation of nicotine. Proc Soc Exp Biol Med 20 (1992) 159-164
8. Weber G.F., and Ashkar S. Stress response genes-the genes that make cancer metastasize. J Mol Med 78 (2000) 404-408
9. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D., and Berman J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107 (2001) 1055-1061
10. Khan S.A., Cook A.C., Kappil M., Günthert U., Chambers A.F., Tuck A.B., et al. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis 22 (2005) 663-673
11. He B., Mirza M., and Weber G.F. An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 25 (2006) 2192-2202
12. Kon S., Maeda M., Segawa T., Hagiwara Y., Horikoshi Y., Chikuma S., et al. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J Cell Biochem 77 (2000) 487-498
13. Crawford H.C., Matrisian L.M., and Liaw L. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res 58 (1998) 5206-5215
14. Kasugai S., Zhang Q., Overall C.M., Wrana J.L., Butler W.T., and Sodek J. Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumor promoter. Bone Miner 13 (1991) 235-250
15. Takafuji V., Forgues M., Unsworth E., Goldsmith P., and Wang X.W. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 26 (2007) 6361-6371
16. Mirza M., Shaughnessy E., Hurley J.K., Vanpatten K.A., Pestano G.A., He B., et al. Osteopontin-c is a selective marker of breast cancer. Int J Cancer 122 (2008) 889-897
17. Koopmann J., Rosenzweig C.N., Zhang Z., Canto M.I., Brown D.A., Hunter M., et al. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res 12 (2006) 442-446
18. Chipitsyna G., Gong Q., Anandanadesan R., Alnajar A., Batra S.K., Denhardt D.T., et al. Induction of osteopontin (OPN) expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. Int J Cancer 125 (2009) 276-285
19. Brown L.F., Papadopoulos-Sergiou A., Berse B., Manseau E.J., Tognazzi K., Perruzzi C.A., et al. Osteopontin expression and distribution in human carcinomas. Am J Pathol 145 (1994) 610-623
20. Lin Y.H., and Yang-Yen H.F. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3- kinase/Akt signaling pathway. J Biol Chem 276 (2001) 46024-46030
21. Mi Z., Guo H., Wai P.Y., Gao C., and Kuo P.C. Integrin linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Carcinogenesis 27 (2006) 1134-1145
22. Chakraborty G., Jain S., and Kundu G.C. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 68 (2008) 152-161
23. Tuck A.B., Hota C., Wilson S.M., and Chambers A.F. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene 22 (2003) 1198-1205
24. Wai P.Y., Guo L., Gao C., Mi Z., Guo H., and Kuo P.C. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 40 (2006) 132-140
25. Kolb A., Kleeff J., Guweidhi A., Esposito I., Giese N.A., Adwan H., et al. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther 4 (2005) 740-746